Hailey Murphy Engineering AssociateAIChEHailey is currently an Engineering Associate at the American Institute of Chemical Engineers and works primarily with the Society for Biological Engineering. She graduated from the University of Delaware in 2017 with a Bachelors in Biomedical Engineering. During her undergraduate career, she was an undergraduate researcher in a nanomedicine lab, and interned at LafargeHolcim as an environmental compliance intern (2014-2016). After graduation, she worked as an associate scientist in an immunobioanalysis laboratory at Quest Pharmaceutical Services (QPS) in their translational medicine department. ChEnected contributions Reshma Shetty on Designing Biology [Interview] Mar 21, 2019 . by Hailey Murphy Synthetic Biology: Engineering, Evolution & Design (SEED) is a conference that brings together professors and lik John Sofranko on Building a Chemical Startup Mar 1, 2019 . by Hailey Murphy Chemical industry entrepreneur John Sofranko talks about his background, building a business, and about his company's goals and challenges. Jack Szostak on Synthetic Biology [Interview] Feb 27, 2019 . by Hailey Murphy Jack Szostak shares his hopes for what synthetic biology can accomplish and what attendees can expect from the rich conversation about synthetic biology at the SEED conference. Wayne Tamarelli on Chemical Ventures Feb 8, 2019 . by Hailey Murphy Angel investor Wayne Tamarelli discusses trends for chemical startups and what you can expect form the Chemical Ventures Conference. CAR T-Cell Therapy Individualizes Cancer Treatment Dec 27, 2018 . by Hailey Murphy The market for chimeric antigen receptor (CAR) T-cell therapy is projected to be valued at almost $300 million by the end of 2018, and this number is expected to grow annually by 32% for the next decade.